We review the current status of ketamine as a Schedule III drug, its DEA regulation and FDA classification, and their impact on applications, research, and insurance coverage.
Synthesized by Calvin Stevens, pushed through clinical trials by Domino and Corssen, and researched by more and more scientific and medical pioners: we explore prominent figures in ketamine’s development in the last 50+ years.
As patients explore ketamine as a treatment option, they often encounter two primary methods of administration: intramuscular (IM) injections and intravenous (IV) infusions. Understanding the differences between these two methods can help patients make informed decisions about treatment.
Just a few years ago, ketamine was known mainly as an anesthetic and a party drug. Today, it’s prominent in headlines and specialized clinics nationwide. We explore the research, market trends, and the surge of ketamine clinics, examining why it’s increasingly accepted for treating depression and other mental health issues.
Research has highlighted ketamine’s anti-inflammatory properties, which could have significant implications for treating various inflammatory conditions. This blog explores how ketamine interacts with inflammatory cells and cytokines, and what these interactions mean biologically and physically, especially for chronic pain related conditions.
Integration is essential following ketamine therapy, both for efficacy and long-term success. Learn about the key components of effective integration and how it can enhance long-term outcomes for mental health treatment.
Psychedelic integration is the process of drawing insight from an often enigmatic experience. Learn how preparation and integration coaches support individuals before, during, and after psychedelic experiences, enhancing safety, meaning, and long-term benefits of these transformative journeys.
Learn about ketamine and esketamine’s molecular structures, FDA approvals, administration methods, and effectiveness in treating depression and other mental health conditions.
Ketamine, once known primarily as an anesthetic, is emerging as a groundbreaking treatment for anxiety disorders. Learn about its mechanisms, effectiveness, and what to expect from ketamine therapy for anxiety, including generalized anxiety, social anxiety, and anxiety related to PTSD.
Learn about the current state of insurance coverage for ketamine, including the only FDA-approved option, Spravato, and explore other forms of medical ketamine treatments for mental health.
We review the current status of ketamine as a Schedule III drug, its DEA regulation and FDA classification, and their impact on applications, research, and insurance coverage.
Synthesized by Calvin Stevens, pushed through clinical trials by Domino and Corssen, and researched by more and more scientific and medical pioners: we explore prominent figures in ketamine’s development in the last 50+ years.
As patients explore ketamine as a treatment option, they often encounter two primary methods of administration: intramuscular (IM) injections and intravenous (IV) infusions. Understanding the differences between these two methods can help patients make informed decisions about treatment.
Just a few years ago, ketamine was known mainly as an anesthetic and a party drug. Today, it’s prominent in headlines and specialized clinics nationwide. We explore the research, market trends, and the surge of ketamine clinics, examining why it’s increasingly accepted for treating depression and other mental health issues.
Research has highlighted ketamine’s anti-inflammatory properties, which could have significant implications for treating various inflammatory conditions. This blog explores how ketamine interacts with inflammatory cells and cytokines, and what these interactions mean biologically and physically, especially for chronic pain related conditions.
Integration is essential following ketamine therapy, both for efficacy and long-term success. Learn about the key components of effective integration and how it can enhance long-term outcomes for mental health treatment.
Psychedelic integration is the process of drawing insight from an often enigmatic experience. Learn how preparation and integration coaches support individuals before, during, and after psychedelic experiences, enhancing safety, meaning, and long-term benefits of these transformative journeys.
Learn about ketamine and esketamine’s molecular structures, FDA approvals, administration methods, and effectiveness in treating depression and other mental health conditions.
Ketamine, once known primarily as an anesthetic, is emerging as a groundbreaking treatment for anxiety disorders. Learn about its mechanisms, effectiveness, and what to expect from ketamine therapy for anxiety, including generalized anxiety, social anxiety, and anxiety related to PTSD.
Learn about the current state of insurance coverage for ketamine, including the only FDA-approved option, Spravato, and explore other forms of medical ketamine treatments for mental health.
